Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing gabapentin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
1 |
Gabapentin measurement |
Component |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
1 |
Gabapentin poisoning |
Causative agent (attribute) |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
1 |
Accidental gabapentin poisoning |
Causative agent (attribute) |
False |
Gabapentin (substance) |
Inferred relationship |
Some |
|
Intentional gabapentin poisoning |
Causative agent (attribute) |
False |
Gabapentin (substance) |
Inferred relationship |
Some |
|
intoxication par la gabapentine d'intention indéterminée |
Causative agent (attribute) |
False |
Gabapentin (substance) |
Inferred relationship |
Some |
1 |
Gabapentin adverse reaction |
Causative agent (attribute) |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
1 |
Allergy to gabapentin (finding) |
Causative agent (attribute) |
False |
Gabapentin (substance) |
Inferred relationship |
Some |
|
Gabapentin overdose |
Causative agent (attribute) |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
1 |
Accidental gabapentin overdose |
Causative agent (attribute) |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
1 |
Intentional gabapentin overdose |
Causative agent (attribute) |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
1 |
surdose de gabapentine d'intention indéterminée |
Causative agent (attribute) |
False |
Gabapentin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely gabapentin 100 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gabapentin (substance) |
Inferred relationship |
Some |
|
Gabapentin 300 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gabapentin (substance) |
Inferred relationship |
Some |
|
Product containing precisely gabapentin 400 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gabapentin (substance) |
Inferred relationship |
Some |
|
Gabapentin 600 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gabapentin (substance) |
Inferred relationship |
Some |
|
Gabapentin 800 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gabapentin (substance) |
Inferred relationship |
Some |
|
Serum gabapentin level (procedure) |
Component |
False |
Gabapentin (substance) |
Inferred relationship |
Some |
2 |
Gabapentin 300mg capsule and 600mg tablet titration pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gabapentin (substance) |
Inferred relationship |
Some |
|
Gabapentin 50 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gabapentin (substance) |
Inferred relationship |
Some |
|
Accidental gabapentin poisoning |
Causative agent (attribute) |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
1 |
Intentional gabapentin poisoning |
Causative agent (attribute) |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
1 |
Allergy to gabapentin (finding) |
Causative agent (attribute) |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
1 |
Gabapentin enacarbil |
Is a |
False |
Gabapentin (substance) |
Inferred relationship |
Some |
|
Product containing precisely gabapentin 100 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gabapentin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely gabapentin 100 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
1 |
Gabapentin 300 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gabapentin (substance) |
Inferred relationship |
Some |
1 |
Gabapentin 300 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely gabapentin 400 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gabapentin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely gabapentin 400 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
1 |
Gabapentin 600 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gabapentin (substance) |
Inferred relationship |
Some |
1 |
Gabapentin 600 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
1 |
Gabapentin 800 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gabapentin (substance) |
Inferred relationship |
Some |
1 |
Gabapentin 800 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
1 |
Gabapentin enacarbil |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
|
Gabapentin 600 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
1 |
Gabapentin 800 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
1 |
Gabapentin 300 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely gabapentin 400 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely gabapentin 100 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
1 |
Product containing gabapentin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
1 |
Gabapentin 50 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
1 |
Gabapentin 50 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
1 |
Product containing only gabapentin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
1 |
Product containing only gabapentin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
1 |
Gabapentin- and nortriptyline-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
2 |
Gabapentin and nortriptyline only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
2 |
Product containing gabapentin and nortriptyline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
2 |
Product containing only gabapentin and nortriptyline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
2 |
Gabapentin 100 mg and nortriptyline (as nortriptyline hydrochloride) 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
2 |
Gabapentin 100 mg and nortriptyline (as nortriptyline hydrochloride) 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely gabapentin 400 milligram and nortriptyline (as nortriptyline hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely gabapentin 400 milligram and nortriptyline (as nortriptyline hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
2 |
Product containing gabapentin and mecobalamin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
2 |
Gabapentin and mecobalamin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
2 |
Product containing gabapentin and mecobalamin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
2 |
Gabapentin and mecobalamin only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
2 |
Gabapentin 300 mg and mecobalamin 500 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
2 |
Gabapentin 300 mg and mecobalamin 500 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
2 |
Serum gabapentin level (procedure) |
Component |
True |
Gabapentin (substance) |
Inferred relationship |
Some |
1 |